Transcode Therapeutics P/B

P/B (Price-to-Book Ratio) of Transcode Therapeutics is -4.23 in 2026.

P/B (Price-to-Book Ratio) of Transcode Therapeutics changed from 5.20 to -4.23, representing a -181.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Transcode Therapeutics with sector peers and the industry average to assess whether it is attractive.